ANTIGENIC EPITOPES OF NEF PROTEINS FROM DIFFERENT HIV-1 STRAINS AS RECOGNIZED BY SERA FROM PATIENTS WITH MANIFEST AND LATENT HIV-INFECTION

被引:39
作者
GOMBERT, FO
BLECHA, W
TAHTINEN, M
RANKI, A
PFEIFER, S
TROGER, W
BRAUN, R
MULLERLANTZSCH, N
JUNG, G
RUBSAMENWAIGMANN, H
KROHN, K
机构
[1] UNIV TAMPERE,INST BIOMED SCI,TAMPERE,FINLAND
[2] EBERHARD KARLS UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN,GERMANY
[3] GEORG SPEYER HAUS,PAUL EHRLICH INST,FRANKFURT,GERMANY
[4] UNIV HELSINKI,CENT HOSP,DEPT DERMATOL,SF-00100 HELSINKI 10,FINLAND
[5] UNIV HEIDELBERG,INST MED VIROL,W-6900 HEIDELBERG,GERMANY
[6] INST MICROBIOL & HYG,W-6650 HOMBURG,GERMANY
关键词
D O I
10.1016/0042-6822(90)90015-J
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV) infection that generally causes a strong antibody response toward HIV may sometimes occur in a latent form, characterized by seronegativity in assays based on structural HIV proteins. Latently infected individuals, however, often have an antibody response against the nonstructural regulatory HIV-1 protein NEF, a factor implicated in down-regulation of viral expression. In order to define the specificity of NEF antibodies, we looked for antibody response against more than 600 overlapping nonapeptides representing the total NEF sequence of three different HIV-1 isolates BRU, SF2, and MAL. Nine distinct homologous antigenic epitopes were recognized by sera from seropositive HIV-1-infected individuals by the peptide ELISA. We further demonstrated that sera from "at risk" individuals, with no antibodies to HIV structural proteins but reacting with the recombinant NEF protein in Western blot, recognize the same epitopes. Immunological assays based on the defined NEF epitopes can therefore be used to diagnose early or latent HIV infection. © 1990.
引用
收藏
页码:458 / 466
页数:9
相关论文
共 23 条
  • [1] NEF PROTEIN OF HIV-1 IS A TRANSCRIPTIONAL REPRESSOR OF HIV-1 LTR
    AHMAD, N
    VENKATESAN, S
    [J]. SCIENCE, 1988, 241 (4872) : 1481 - 1485
  • [2] ANTIBODIES TO THE NEF PROTEIN AND TO NEF PEPTIDES IN HIV-1-INFECTED SERONEGATIVE INDIVIDUALS
    AMEISEN, JC
    GUY, B
    CHAMARET, S
    LOCHE, M
    MOUTON, Y
    NEYRINCK, JL
    KHALIFE, J
    LEPREVOST, C
    BEAUCAIRE, G
    BOUTILLON, C
    GRASMASSE, H
    MANIEZ, M
    KIENY, MP
    LAUSTRIAT, D
    BERTHIER, A
    MACH, B
    MONTAGNIER, L
    LECOCQ, JP
    CAPRON, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (03) : 279 - 291
  • [3] SPECIFIC ANTIBODIES ELICITED BY ANTIGEN COVALENTLY LINKED TO A SYNTHETIC ADJUVANT
    BESSLER, WG
    SUHR, B
    BUHRING, HJ
    MULLER, CP
    WIESMULLER, KH
    BECKER, G
    JUNG, G
    [J]. IMMUNOBIOLOGY, 1985, 170 (03) : 239 - 244
  • [4] BIBERFELD G, 1986, LANCET, V2, P289
  • [5] DISTINCTION BETWEEN HIV-1 AND HIV-2 INFECTION USING NOVEL SYNTHETIC LIPOPEPTIDE CONJUGATES AS ANTIGENS IN ENZYME IMMUNOASSAYS
    BOLTZ, T
    HUMMEL, RP
    TROGER, W
    RUBSAMENWAIGMANN, H
    BIESERT, L
    MULLERLANTZSCH, N
    KOCH, P
    BESSLER, W
    JUNG, G
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1988, 22 (2-3) : 173 - 182
  • [6] CIAMPOLILLO A, 1989, LANCET, V1, P1096
  • [7] ANALYSIS OF ACCURACY AND IMPLICATIONS OF SIMPLE METHODS FOR PREDICTING SECONDARY STRUCTURE OF GLOBULAR PROTEINS
    GARNIER, J
    OSGUTHORPE, DJ
    ROBSON, B
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1978, 120 (01) : 97 - 120
  • [8] STRATEGIES FOR EPITOPE ANALYSIS USING PEPTIDE-SYNTHESIS
    GEYSEN, HM
    RODDA, SJ
    MASON, TJ
    TRIBBICK, G
    SCHOOFS, PG
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 102 (02) : 259 - 274
  • [9] USE OF PEPTIDE-SYNTHESIS TO PROBE VIRAL-ANTIGENS FOR EPITOPES TO A RESOLUTION OF A SINGLE AMINO-ACID
    GEYSEN, HM
    MELOEN, RH
    BARTELING, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13): : 3998 - 4002
  • [10] HIV-1, HTLV-1 AND NORMAL T-CELL GROWTH - TRANSCRIPTIONAL STRATEGIES AND SURPRISES
    GREENE, WC
    BOHNLEIN, E
    BALLARD, DW
    [J]. IMMUNOLOGY TODAY, 1989, 10 (08): : 272 - 278